Clinical Trials Browser

Phase 4 × INDUSTRY × Infliximab × Clear all

NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Phase 4 Completed

1 enrolled 1 chart

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases